title: Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
abstract: Recent studies have suggested that Crk-like adapter protein (CrkL) and epithelial-to-mesenchymal transition (EMT) induced by CCL19/CCR7 play an important role in ovarian epithelial carcinogenesis. However, the regulatory mechanisms of CrkL on the CCL19/CCR7 signaling pathways in epithelial ovarian carcinomas (EOC) are not well characterized. Here, CCR7 and CrkL proteins were tested in 30 EOC tissues and cell lines. In vitro, the roles of CrkL in CCL19-stimulated SKOV-3 cell invasion and migration were investigated. In this work, CCR7 and CrkL over-expressed in EOC tissues and cell lines and correlated with FIGO stage and lymph node metastasis. Moreover, CCR7 and CrkL serve as an independent prognostic factor. In SKOV-3 cells, CrkL knockdown markedly suppressed the CCL19-stimulated expression of p-ERK and EMT biomarkers (N-cadherin, Snail and MMP9), compared with control. In contrast, p-AKT expression level did not change. On the other hand, functional analysis revealed CrkL knockdown could significantly decrease SKOV-3 cell invasion number of transwell invasion assay, and wound closure area of wound healing assay, compared to control. In conclusion, CrkL regulates CCL19/CCR7-induced EMT via ERK signaling pathway in EOC patients, which further suggested CrkL could be suggested as an efficient target in ovarian cancer treatment.
authors: Department of Gynecology, Affiliated Hospital of Shandong Academy of Medical Sciences, 38# Wuyingshan Road, Jinan, 250031, Shandong, China, chengsmshandong@163.com.
authors: Shaomei
authors: S
authors: Cheng
authors: Jingyan
authors: J
authors: Guo
authors: Qing
authors: Q
authors: Yang
authors: Xiangshan
authors: X
authors: Yang
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000077216:Carcinoma, Ovarian Epithelial; D045744:Cell Line, Tumor; D002465:Cell Movement; D054415:Chemokine CCL19 / Q000378:metabolism*; D058750:Epithelial-Mesenchymal Transition; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008207:Lymphatic Metastasis; D020935:MAP Kinase Signaling System; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000401:mortality / Q000473:pathology*; D011379:Prognosis; D054400:Receptors, CCR7 / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C515460:CCL19 protein, human; C515370:CCR7 protein, human; C082869:CRKL protein; D054415:Chemokine CCL19; D009687:Nuclear Proteins; D054400:Receptors, CCR7
references: J Clin Invest. 2007 Dec;117(12 ):3810-20
references: 18037992
references: Tumour Biol. 2014 Dec;35(12 ):12293-8
references: 25168373
references: Am J Pathol. 2010 Sep;177(3):1053-64
references: 20651229
references: Cell. 2009 Nov 25;139(5):871-90
references: 19945376
references: Am J Pathol. 2004 May;164(5):1511-8
references: 15111296
references: BMC Genomics. 2014 Dec 23;15:1169
references: 25540073
references: Liver Int. 2010 May;30(5):669-82
references: 20158611
references: Cell Commun Signal. 2009 May 10;7:13
references: 19426560
references: Curr Pharm Des. 2006;12(3):341-9
references: 16454748
references: Ann Oncol. 2010 Oct;21 Suppl 7:vii89-92
references: 20943648
references: J Cell Biochem. 2014 May;115(5):819-25
references: 24356912
references: Genes Cancer. 2010 Nov;1(11):1132-9
references: 21779437
references: Future Oncol. 2014 Dec;10(16):2687-97
references: 25531052
references: Tumour Biol. 2014 May;35(5):4101-6
references: 24375195
references: Biochem Pharmacol. 2013 Feb 15;85(4):478-85
references: 23159669
references: Histopathology. 2013 Jan;62(1):59-70
references: 23240670
references: N Engl J Med. 2001 Sep 13;345(11):833-5
references: 11556308
references: Exp Hematol. 2012 Dec;40(12):1055-9
references: 22960265
references: Int J Oncol. 2014 Dec;45(6):2502-10
references: 25270024
references: Clin Cancer Res. 2003 Aug 15;9(9):3406-12
references: 12960129
references: Nat Rev Clin Oncol. 2013 Apr;10(4):211-24
references: 23381004
references: Microcirculation. 2003 Jun;10(3-4):325-34
references: 12851649
references: Lung Cancer. 2014 Aug;85(2):147-51
references: 24939008
references: Eur J Immunol. 2012 Aug;42(8):1949-55
references: 22700449
references: J Biol Chem. 1996 Jun 14;271(24):14468-72
references: 8662907